Integra LifeSciences Holdings Corporation IART
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -1.81% | 6.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.81% | 6.85% | |||
| Cost of Revenue | -1.14% | 13.21% | |||
| Gross Profit | -2.34% | 2.30% | |||
| SG&A Expenses | -3.11% | 1.25% | |||
| Depreciation & Amortization | -0.32% | -0.16% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.36% | 7.79% | |||
| Operating Income | 3.37% | -1.22% | |||
| Income Before Tax | 230.19% | 296.93% | |||
| Income Tax Expenses | 209.92% | -88.13% | |||
| Earnings from Continuing Operations | 231.37% | 197.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 231.37% | 197.08% | |||
| EBIT | 3.37% | -1.22% | |||
| EBITDA | 2.91% | -1.00% | |||
| EPS Basic | 230.86% | 196.67% | |||
| Normalized Basic EPS | 12.78% | -4.51% | |||
| EPS Diluted | 227.59% | 196.67% | |||
| Normalized Diluted EPS | 12.32% | -5.56% | |||
| Average Basic Shares Outstanding | 0.12% | 0.44% | |||
| Average Diluted Shares Outstanding | 0.52% | 1.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||